Healthy Human Volunteers Clinical Trial
Official title:
Standardized Hibiscus Sabdariffa Linn Tea, Potential Nutraceutical Candidate for the Prevention of Hypertension, Diabetes, and Hypercholesterolemia - a Pilot Study
Hibiscus sabdariffa tea is commonly used all over the world by healthy individual but the tea is also employed by patients in the management of chronic diseases such as hypertension diabetes, high cholesterol, liver disease etc. Several studies in humans and animal have proved the efficacy of Hibiscus sabdariffa tea in lowering blood pressure, blood glucose level and serum total cholesterol. But no study exists on the effect of daily consumption of this tea on blood pressure, blood glucose, total cholesterol and other biochemical and hematological parameters in healthy humans. Hence this study.
Several studies have been carried out on the effect of the water beverage of Hibiscus
sabdariffa, most focus on hypertensive patients, diabetic patients and obese patient and some
studies investigated the hypolipidemic a effect of the water beverage of Hibiscus sabdariffa
as well as its effect on haematological parameters but mice were used for these studies.
Little or no investigation has been done to assess the safety of daily consumption of this
water beverage of hibiscus sabdariffa on humans.
Hence, this study aims at investigating the safety in the daily consumption of Zobo in
humans, monitoring lipid profile, blood pressure, blood glucose, body mass index and
haematological parameters such as haematocrit, haemoglobin, total white blood cells and also
hepatic indices.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00765427 -
Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00813670 -
Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02219438 -
Continuous Adductor Canal Nerve Blocks: Relative Effects of a Basal Infusion v. Hourly Bolus Doses
|
Phase 4 |